HLA-B*1502 Genotyping Carbamazepine Test
Introduction
The HLA-B*1502 Genotyping Carbamazepine test is a crucial genetic test designed to assess an individual’s risk of developing serious skin reactions when taking Carbamazepine, a common medication used for epilepsy and bipolar disorder. This test is especially important for individuals of Asian descent, as they are at a higher risk of adverse reactions. Understanding your genetic makeup can help guide safe medication choices and improve treatment outcomes.
What the Test Measures
This test specifically detects the presence of the HLA-B*1502 allele, which is associated with an increased risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients treated with Carbamazepine. Knowing your HLA-B*1502 status can significantly influence your treatment plan.
Who Should Consider This Test
Individuals who should consider the HLA-B*1502 Genotyping Carbamazepine test include:
- Patients of Asian descent, particularly those from Han Chinese, Thai, or Malay backgrounds.
- Individuals with a family history of adverse drug reactions to Carbamazepine.
- Patients who have been prescribed Carbamazepine for epilepsy or mood disorders.
Benefits of Taking the Test
Taking the HLA-B*1502 Genotyping Carbamazepine test offers several benefits:
- Personalized Treatment: Helps healthcare providers tailor medication plans based on genetic risk.
- Increased Safety: Reduces the risk of severe adverse reactions to Carbamazepine.
- Informed Decision-Making: Empowers patients to make informed choices about their treatment options.
Understanding Your Results
Results from the HLA-B*1502 Genotyping test will indicate whether the HLA-B*1502 allele is present:
- Positive Result: Indicates the presence of the allele, suggesting a higher risk of adverse reactions to Carbamazepine.
- Negative Result: Indicates a lower risk, allowing for safer use of Carbamazepine.
Test Name and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| HLA-B*1502 Genotyping Carbamazepine | 10,500 KSh | 14,000 KSh |
Sample Collection and Turnaround Time
The test requires a sample of peripheral blood collected using an EDTA Vacutainer (2ml). The turnaround time for results is approximately 10 days.
Pre-Test Instructions
The HLA-B*1502 Genotyping test can be conducted with a Doctor’s prescription. Note that a prescription is not required for surgery and pregnancy cases or for individuals planning to travel abroad.
Branches Across Kenya
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. For your convenience, we also offer home sample collection services.
Book Your Test Today!
Don’t wait to ensure your safety when using Carbamazepine. Book the HLA-B*1502 Genotyping Carbamazepine test today! For inquiries, call or WhatsApp us at +254746849631.
